missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. 18139187

Factor XII heavy chain Antibody (10-11-37), DyLight 755, Novus Biologicals™

Mouse Monoclonal Antibody

Brand:  Novus Biologicals NBP2-41377IR

Product Code. 18139187

  • € 711.00 / 0.10mL

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

Factor XII heavy chain Monoclonal specifically detects Factor XII heavy chain in Human samples. It is validated for Western Blot, ELISA, Sandwich ELISA.
TRUSTED_SUSTAINABILITY
Specifications

Specifications

Factor XII heavy chain
Monoclonal
DyLight 755
50mM Sodium Borate with 0.05% Sodium Azide
F12
Affinity purified human factor XII.
0.1 mL
2161
Human
Purified
Western Blot, ELISA
13799
Western Blot, ELISA, Sandwich ELISA
beta-factor XIIa part 1, coagulation factor XII, coagulation factor XII (Hageman factor), coagulation factor XIIa heavy chain, coagulation factor XIIa light chain, EC 3.4.21, EC 3.4.21.38, HAE3, HAEX, HAFbeta-factor XIIa part 2, Hageman factor
Mouse
Protein A or G purified
Primary
Antibody binds the heavy chain of human factor XII, including factor XII derivatives such as a-factor XIIa and a-factor XIIa C1-inhibitor complexes.
Store at 4C in the dark.
IgG2a κ
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.